ロード中...
GUCY2C-directed CAR-T cells oppose colorectal cancer metastases without autoimmunity
Adoptive T-cell therapy (ACT) is an emerging paradigm in which T cells are genetically modified to target cancer-associated antigens and eradicate tumors. However, challenges treating epithelial cancers with ACT reflect antigen targets that are not tumor-specific, permitting immune damage to normal...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5087292/ https://ncbi.nlm.nih.gov/pubmed/27853651 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1227897 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|